Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiankai Sun

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Cancer Discovery|October 9, 2025
HIF-2-Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell CarcinomaArijit Mal, Bingqing Xie, Zane Gray, et al.
Nature Metabolism|December 1, 2020
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancerJiyeon Kim, Hyun Min Lee, Feng Cai, et al.
Cancer Cell|October 19, 2013
The role of Cdk5 in neuroendocrine thyroid cancerKarine Pozo, Emely Castro-Rivera, Chunfeng Tan, et al.
Cell Reports|November 24, 2021
A renal cell carcinoma tumorgraft platform to advance precision medicineRoy Elias, Vanina T Tcheuyap, Akash K Kaushik, et al.
Science Advances|December 16, 2022
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinomaAkash K Kaushik, Amy Tarangelo, Lindsey K Boroughs, et al.
Nature|September 6, 2016
Targeting renal cell carcinoma with a HIF-2 antagonistWenfang Chen, Haley Hill, Alana Christie, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Cancer Discovery|October 9, 2025
HIF-2-Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell CarcinomaArijit Mal, Bingqing Xie, Zane Gray, et al.
Nature Metabolism|December 1, 2020
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancerJiyeon Kim, Hyun Min Lee, Feng Cai, et al.
Cancer Cell|October 19, 2013
The role of Cdk5 in neuroendocrine thyroid cancerKarine Pozo, Emely Castro-Rivera, Chunfeng Tan, et al.
Cell Reports|November 24, 2021
A renal cell carcinoma tumorgraft platform to advance precision medicineRoy Elias, Vanina T Tcheuyap, Akash K Kaushik, et al.
Science Advances|December 16, 2022
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinomaAkash K Kaushik, Amy Tarangelo, Lindsey K Boroughs, et al.
Nature|September 6, 2016
Targeting renal cell carcinoma with a HIF-2 antagonistWenfang Chen, Haley Hill, Alana Christie, et al.
Pageof 18